NIH’s, the ITM’s parent organization, National Cancer Institute will award $6.25 million to up to five projects that develop innovative strategies to study of tumor resistance to anticancer therapy; strategies that can eventually be used in clinical settings.

Learn more and submit your application.

Source: NIH